The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of the PI3Kβ inhibitor GSK2636771 in combination with pembrolizumab (P) in patients (pts) with PD-1 refractory metastatic melanoma (MM) and PTEN loss.
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst)
 
Weiyi Peng
No Relationships to Disclose
 
Denai Milton
No Relationships to Disclose
 
Rodabe Navroze Amaria
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Isabella Claudia Glitza
Travel, Accommodations, Expenses - Lilly
 
Wen-Jen Hwu
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck/Schering Plough
 
Sapna Pradyuman Patel
Stock and Other Ownership Interests - Provectus
Honoraria - PCME, Rockpointe; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Cardinal Health; Castle Biosciences; Incyte
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Castle Biosciences; Incyte; Massachusetts General Hospital; PCME, Rockpointe; Socrates Analytics
 
Michael K.K. Wong
Consulting or Advisory Role - Merck; Pfizer
 
Scott Eric Woodman
No Relationships to Disclose
 
Cassian Yee
Consulting or Advisory Role - Adaptive Biotechnologies; Immatics
Patents, Royalties, Other Intellectual Property - Invention for use of IL21
 
Jennifer Leigh McQuade
No Relationships to Disclose
 
Michael T. Tetzlaff
Consulting or Advisory Role - Myriad Genetics; Novartis
 
Alexander J. Lazar
Employment - GE Healthcare (I)
Leadership - Archer; Beta Cat Pharmaceuticals
Stock and Other Ownership Interests - Archer; Beta Cat Pharmaceuticals
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Consulting or Advisory Role - GE Healthcare; Illumina; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Suzanne Cain
No Relationships to Disclose
 
Elizabeth M. Burton
No Relationships to Disclose
 
Jan Hendrik Beumer
Employment - Cardinal Health (I); GlaxoSmithKline (I); Voisin Consulting (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - BTG
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Millennium (Inst); Novartis (Inst); Saladax Biomedical (Inst); Spectrum Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Sulphoraphane for melanoma chemoprevention (Inst)
 
Patrick Hwu
Stock and Other Ownership Interests - Immatics; Iovance Biotherapeutics
Consulting or Advisory Role - Dragonfly Therapeutics; GlaxoSmithKline; Immatics; Iovance Biotherapeutics; Sanofi
Research Funding - Genentech (Inst)
 
Michael A. Davies
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; NanoString Technologies; Novartis; Sanofi; Syndax; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)